{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:49:39Z","timestamp":1786736979678,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Res Med Sci"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jrms.jrms_759_19","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T08:57:49Z","timestamp":1595840269000},"page":"69","source":"Crossref","is-referenced-by-count":7,"title":["Study of T-cell immunoglobulin and mucin domain-3 expression profile in peripheral blood and bone marrow of human acute lymphoblastic leukemia patients"],"prefix":"10.4103","volume":"25","author":[{"given":"Mahmoud","family":"Aghaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NargesZargar","family":"Balajam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoureh","family":"Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Kompani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1735-1995.291016-1","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","author":"Inaba","year":"2013","journal-title":"Lancet"},{"key":"key-10.4103\/1735-1995.291016-2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key-10.4103\/1735-1995.291016-3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri1111","article-title":"The TIM gene family: Emerging roles in immunity and disease","author":"Kuchroo","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"key-10.4103\/1735-1995.291016-4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","author":"Monney","year":"2002","journal-title":"Nature"},{"key":"key-10.4103\/1735-1995.291016-5","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.273.7.4135","article-title":"Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury","author":"Ichimura","year":"1998","journal-title":"J Biol Chem"},{"key":"key-10.4103\/1735-1995.291016-6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.0105-2896.2010.00903.x","article-title":"TIM genes: A family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity","author":"Freeman","year":"2010","journal-title":"Immunol Rev"},{"key":"key-10.4103\/1735-1995.291016-7","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.4049\/jimmunol.177.7.4281","article-title":"Preferential involvement of Tim-3 in the regulation of hepatic CD8+T cells in murine acute graft-versus-host disease","author":"Oikawa","year":"2006","journal-title":"J Immunol"},{"key":"key-10.4103\/1735-1995.291016-8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/cmi.2013.57","article-title":"The impact of the TIM gene family on tumor immunity and immunosuppression","author":"Baghdadi","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"key-10.4103\/1735-1995.291016-9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.20090397","article-title":"Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion","author":"Huang","year":"2010","journal-title":"J Exp Med"},{"key":"key-10.4103\/1735-1995.291016-10","doi-asserted-by":"crossref","first-page":"e53834","DOI":"10.1371\/journal.pone.0053834","article-title":"Tim-3 expression in cervical cancer promotes tumor metastasis","author":"Cao","year":"2013","journal-title":"PLoS One"},{"key":"key-10.4103\/1735-1995.291016-11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.stem.2010.11.014","article-title":"TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells","author":"Kikushige","year":"2010","journal-title":"Cell Stem Cell"},{"key":"key-10.4103\/1735-1995.291016-12","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.7314\/APJCP.2013.14.6.3897","article-title":"Prognostic value of T cell immunoglobulin mucin-3 in prostate cancer","author":"Piao","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"key-10.4103\/1735-1995.291016-13","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1309\/AJCP9Q6OVLVSHTMY","article-title":"Ectopic expression of TIM-3 in lung cancers: A potential independent prognostic factor for patients with NSCLC","author":"Zhuang","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"key-10.4103\/1735-1995.291016-14","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1073\/pnas.1100551108","article-title":"Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker","author":"Jan","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/1735-1995.291016-15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-016-0571-x","article-title":"Targeting acute myeloid leukemia stem cell signaling by natural products","author":"Siveen","year":"2017","journal-title":"Mol Cancer"},{"key":"key-10.4103\/1735-1995.291016-16","first-page":"119","article-title":"Comparative expression profile of orphan receptor tyrosine kinase ROR1 in Iranian patients with lymphoid and myeloid leukemias","author":"Shabani","year":"2011","journal-title":"Avicenna J Med Biotechnol"},{"key":"key-10.4103\/1735-1995.291016-17","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/jcmm.12500","article-title":"Up-regulation of galectin-9 induces cell migration in human dendritic cells infected with dengue virus","author":"Hsu","year":"2015","journal-title":"J Cell Mol Med"},{"key":"key-10.4103\/1735-1995.291016-18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key-10.4103\/1735-1995.291016-19","first-page":"361590","article-title":"The design of a quantitative western blot experiment","author":"Taylor","year":"2014","journal-title":"Biomed Res Int"},{"key":"key-10.4103\/1735-1995.291016-20","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"key-10.4103\/1735-1995.291016-21","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/cas.12695","article-title":"Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy","author":"Adachi","year":"2015","journal-title":"Cancer Sci"},{"key":"key-10.4103\/1735-1995.291016-22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/sj.jid.5700616","article-title":"TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells","author":"Wiener","year":"2007","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/1735-1995.291016-23","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/dna.2013.2116","article-title":"The expression of Tim-3 in peripheral blood of ovarian cancer","author":"Wu","year":"2013","journal-title":"DNA Cell Biol"},{"key":"key-10.4103\/1735-1995.291016-24","first-page":"7029","article-title":"Distinct role of Tim-3 in systemic lupus erythematosus and clear cell renal cell carcinoma","author":"Zheng","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key-10.4103\/1735-1995.291016-25","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/2326-6066.CIR-14-0156","article-title":"The coordinated actions of TIM-3 on cancer and myeloid cells in the regulation of tumorigenicity and clinical prognosis in clear cell renal cell carcinomas","author":"Komohara","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"key-10.4103\/1735-1995.291016-26","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/hep.25777","article-title":"Tim-3\/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"key-10.4103\/1735-1995.291016-27","first-page":"33823","article-title":"Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells","author":"Gon\u00e7alves","year":"2015","journal-title":"Oncotarget"},{"key":"key-10.4103\/1735-1995.291016-28","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.imbio.2016.04.005","article-title":"Tim-3 identifies exhausted follicular helper T cells in breast cancer patients","author":"Zhu","year":"2016","journal-title":"Immunobiology"},{"key":"key-10.4103\/1735-1995.291016-29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.stem.2015.07.011","article-title":"A TIM-3\/Gal-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemic progression","author":"Kikushige","year":"2015","journal-title":"Cell Stem Cell"},{"key":"key-10.4103\/1735-1995.291016-30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.b.21080","article-title":"TIM3 expression by leukemic and non-leukemic myeloblasts","author":"Roth","year":"2013","journal-title":"Cytometry B Clin Cytom"}],"container-title":["Journal of Research in Medical Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:48:28Z","timestamp":1786733308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.JRMS_759_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["291016"],"URL":"https:\/\/doi.org\/10.4103\/jrms.jrms_759_19","relation":{},"ISSN":["1735-1995"],"issn-type":[{"value":"1735-1995","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}